Midas Letter and C-Suite are excited to announce Midas Letter LIVE. Midas Letter highlights the stocks and stories to watch in the Canadian markets today. Host James West is a recognized authority on investing in the emerging company segment having been a regularly featured guest on Business News Network, CNBC, Bloomberg, Reuters, and CTV. James West and guests provide comprehensive fundamental & technical analysis on all trending business and investment news, while interviewing the top CEOs of all public companies and analysts with the highest reputations in the business. Midas Letter is excited to feature all investing content on C-suite.
Khiron Life Sciences Corp (CVE:KHRN) Skin Unit Director on Kuida Brand Multi-Channel Deals
Khiron Life Sciences Corp (CVE:KHRN) (OTCMKTS:KHRNF) (FRA:4KH) Skin Unit Director Elsa Navarro shares details of the company’s recent distribution deal with Fedco, one of Colombia’s most established beauty retailers. Navarro notes the agreement is significant because it provides Khiron with the opportunity to introduce consumers to its CBD products at Fedco’s 22 locations in the country. She also discusses the importance of securing an agreement with Linio for online distribution of Kuida-branded products in Colombia. Navarro explains how Khiron’s proprietary CBDERM technology delivers fast absorption rates with a higher percentage of antioxidants, a key ingredient in anti-aging formulas, than traditional cosmetic products. Navara underscores the importance of Khiron’s participation at the world’s largest beauty event, Cosmoprof Worldwide, in Bologna, Italy. Navarro is pleased with Khiron’s recently announced partnership to conduct clinical skin care trials with distinguished Colombian hospital Centro Dermatológico Federico Lleras Acosta (CDFLLA). The deal is the first of its kind for Latin America and puts Khiron in a leadership position in the cannabis dermacosmetics space.